1526 — Rici Healthcare Holdings Income Statement
0.000.00%
- HK$1.89bn
- HK$3.44bn
- CNY2.99bn
- 61
- 89
- 88
- 95
Annual income statement for Rici Healthcare Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,726 | 1,925 | 2,377 | 2,375 | 2,993 |
Cost of Revenue | |||||
Gross Profit | 484 | 581 | 975 | 927 | 1,250 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,754 | 1,849 | 1,861 | 1,943 | 2,336 |
Operating Profit | -27.4 | 75.8 | 516 | 432 | 657 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -168 | -109 | 392 | 327 | 546 |
Provision for Income Taxes | |||||
Net Income After Taxes | -170 | -92.5 | 294 | 243 | 402 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -69.2 | -7.88 | 182 | 291 | 364 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -69.2 | -7.88 | 182 | 291 | 364 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.044 | -0.006 | 0.182 | 0.13 | 0.216 |
Special Dividends per Share |